Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals.

The findings of this large prospective study reveal an obesity-associated factor that confers an increased risk of multiple myeloma in heavy individuals, with implications for identifying at-risk patients who could benefit from early screening and therapeutic intervention.